BILL ANALYSIS                                                                                                                                                                                                    



                                                                    ACR 161


                                                                    Page  1





          ASSEMBLY THIRD READING


          ACR  
          161 (Waldron)


          As Introduced  March 30, 2016


          Majority vote


           ------------------------------------------------------------------ 
          |Committee       |Votes|Ayes                  |Noes                |
          |                |     |                      |                    |
          |                |     |                      |                    |
          |                |     |                      |                    |
          |----------------+-----+----------------------+--------------------|
          |Rules           |9-0  |Gordon, Chang,        |                    |
          |                |     |Brough, Cooley,       |                    |
          |                |     |Gomez, Holden, Jones, |                    |
          |                |     |Mullin, Quirk         |                    |
          |                |     |                      |                    |
          |                |     |                      |                    |
           ------------------------------------------------------------------ 


          SUMMARY:  Proclaims the month of May 2016 as Bladder Cancer  
          Awareness Month.  Specifically, this resolution makes the  
          following legislative findings: 
          1)Bladder cancer affects adults of all ages and backgrounds ad  
            is the fifth most common non-skin cancer in the United States,  
            exceeded only by breast, lung, prostate, and colon cancers,  
            yet knowledge of the frequency and severity of bladder cancer  
            is minimal.
          2)More than 74,000 people in the United States are expected to  
            be diagnosed with bladder cancer and 16,000 will die due to  
            the disease in 2016 alone.








                                                                    ACR 161


                                                                    Page  2







          3)Bladder cancer is known as one of the most expensive cancers  
            to treat on a per patient basis and has a recurrence rate of  
            approximately 50% to 80%, requiring lifelong surveillance.


          4)If diagnosed early, bladder cancer is treatable, and the  
            quality of life of a person with bladder cancer will depend on  
            future treatment and diagnostic developments, which will rely  
            on research advancements.


          5)Research advancements for bladder cancer are limited by lack  
            of awareness about the disease within the medical community  
            and general public.  Increased awareness will promote early  
            diagnosis and increase the chances of survival.


          6)Increased awareness will bolster public support of treatment  
            of the disease and thus increase funding for innovative  
            research and the development of new treatment options and  
            diagnostic tools.


          FISCAL EFFECT:  None




          Analysis Prepared by:                                             
                          Nicole Willis / RLS. / (916) 319-2800  FN:  
          0002772














                                                                    ACR 161


                                                                    Page  3